Related Experiment Videos
Percutaneous coronary intervention-related bleeding risk factors in current practice
A Scott Mathis1, James J Gugger
1Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, USA. smathis@rci.rutgers.edu
The Annals of Pharmacotherapy
|September 8, 2005
Summary
Severe renal impairment (creatinine clearance <30 mL/min) and antithrombotic choice significantly increase bleeding risk after percutaneous coronary intervention (PCI). These factors are crucial for managing bleeding complications in PCI patients.
Area of Science:
- Cardiology
- Nephrology
- Interventional Cardiology
Background:
- Bleeding complications are frequent and costly after percutaneous coronary intervention (PCI).
- Risk factors for PCI-related bleeding remain incompletely understood.
- Renal function's role in bleeding risk requires further elucidation.
Purpose of the Study:
- To analyze institutional observations from percutaneous coronary intervention (PCI) procedures.
- To identify independent risk factors for short-term bleeding complications.
- To specifically assess the impact of renal function on bleeding risk.
Main Methods:
- Retrospective review of 300 patients undergoing PCI.
- Patients categorized by antithrombotic regimen: heparin alone, bivalirudin, or glycoprotein IIb/IIIa antagonist plus heparin.
- Multivariate analysis to predict bleeding risk factors.
Main Results:
- Antithrombotic regimen, creatinine clearance <30 mL/min, and hypertension predicted any bleeding.
- Creatinine clearance <30 mL/min predicted major bleeding.
- Minor bleeding was solely predicted by antithrombotic regimen choice.
Conclusions:
- Creatinine clearance <30 mL/min and antithrombotic regimen are primary determinants of bleeding risk post-PCI.
- Serum creatinine levels did not predict bleeding events.
- Clinical focus on impaired renal function is vital for bleeding risk assessment.